As cardiovascular disease remains the leading cause of death in the United States, the medical community has been on a quest for the "gold standard" of risk assessment. For years, the coronary artery calcium (CAC) scan—a quick, non-invasive CT test—has been touted as a revolutionary tool. By detecting calcified plaque in the arteries supplying the heart, the scan offers a tangible glimpse into a patient’s cardiovascular future.
However, a landmark study published August 26 in JAMA by researchers at Northwestern Medicine is challenging the "more is better" approach. The findings suggest that while CAC scans are valuable, they are not a universal necessity. Instead, their clinical utility is most significant for a specific, narrow subset of the population, while potentially leading to unnecessary radiation and medical costs for others.
Main Facts: A New Perspective on Cardiovascular Screening
The study, which tracked more than 6,000 adults over a decade, aimed to determine how much the CAC scan actually improves upon existing risk assessment models. Specifically, researchers compared the results of these scans against the American Heart Association’s (AHA) primary cardiovascular risk calculator, known as PREVENT.
The PREVENT tool relies on traditional, easily accessible metrics—age, sex, blood pressure, and cholesterol levels—to estimate the likelihood of a cardiovascular event (such as a heart attack or stroke) occurring within the next 10 or 30 years. The CAC scan, by contrast, physically visualizes the buildup of calcium-containing plaque within the coronary arteries.
The core takeaway from the study is that for the general population, adding the CAC score to the PREVENT calculator yielded only a marginal improvement in predictive accuracy. The model’s "discrimination"—its ability to distinguish between those who would suffer a heart event and those who would not—moved only slightly, from 0.73 to 0.75. This suggests that for most patients, the traditional, free, and non-radiation-based calculator is already highly effective.
Chronology: Following the Data Over a Decade
To reach these conclusions, Dr. Nilay Shah and his team at the Northwestern University Feinberg School of Medicine analyzed data from the long-standing Multi-Ethnic Study of Atherosclerosis. The cohort included more than 6,000 adults between the ages of 45 and 79.
The Baseline
At the inception of the study, each participant underwent a comprehensive assessment. This included obtaining their PREVENT risk score and a coronary artery calcium score via CT imaging. Researchers then observed the participants over the next 10 years to document any cardiovascular events, such as heart attacks or strokes.
The Findings
Over the decade-long study period, 6% of the participants experienced a major cardiovascular event. When researchers compared the predictive accuracy of the PREVENT calculator alone versus a model supplemented by CAC scores, they found that the added value was negligible for the majority of the cohort.
However, a distinct pattern emerged when the researchers isolated participants who were initially categorized as "borderline" or "intermediate" risk (defined as a 3% to 9% risk of a cardiovascular event within 10 years). For this specific demographic, the addition of the calcium score provided a much more meaningful improvement in prediction. It served as a "tie-breaker" of sorts, helping clinicians identify which patients in that middle-ground zone were truly at higher risk and which were likely at lower risk than the initial assessment suggested.
Supporting Data: Why "More" Isn’t Always "Better"
The study highlights a critical tension in modern preventative medicine: the balance between diagnostic thoroughness and the potential for over-medicalization.
Dr. Nilay Shah, the study’s senior author and an assistant professor of medicine in the division of cardiology, emphasized that the ubiquity of CAC scans—driven by their decreasing costs and wider availability—has led to a "more is better" mindset that may be counterproductive.
The Risks of Over-Screening
The researchers pointed to two major downsides of using these scans indiscriminately:
- Low-Risk Populations: For individuals who are already categorized as low-risk based on standard blood work and health metrics, a calcium scan provides little actionable information. Performing the scan on these individuals exposes them to unnecessary ionizing radiation and increases healthcare costs without a clear clinical benefit.
- High-Risk Populations: Conversely, for individuals who are already deemed high-risk based on the PREVENT calculator, the scan is often redundant. These patients generally meet the clinical threshold for aggressive interventions, such as statin therapy, regardless of what the calcium scan reveals. If the treatment path—starting a cholesterol-lowering medication—is already indicated, the additional diagnostic test does not change the management plan.
The study underscores that clinical diagnostics should be used to change or confirm a specific treatment pathway. If the outcome of the test would not lead a physician to alter the patient’s medication, lifestyle plan, or follow-up schedule, the test itself becomes a costly, unnecessary hurdle.
Official Responses and Clinical Implications
The research team, which included experts from various disciplines at Northwestern, including Xiaoning Huang, Lucia Petito, and Dr. Sadiya Khan, posits that these findings should fundamentally shift how physicians utilize the PREVENT tool in clinical practice.
"Our findings suggest that not everyone necessarily needs or would benefit from a coronary artery calcium scan for the purpose of predicting risk of heart attack and stroke," Dr. Shah noted. Instead, the goal should be to use these resources with precision.
Precision Medicine
The real value of the CAC scan, according to the study, lies in the "borderline" or "intermediate" zone. When a physician is uncertain whether to prescribe a statin or rely strictly on lifestyle modifications, the calcium score acts as a tie-breaker. A high calcium score in an intermediate-risk patient can provide the "nudge" needed to start preventive therapy, while a zero score might reassure a patient and physician that they can safely monitor the situation without pharmacological intervention.
The study also provides a vote of confidence for the PREVENT equations themselves. By demonstrating that the calculator holds its own even without the addition of complex imaging, the authors suggest that for the vast majority of patients, a thorough assessment of traditional health markers is the most efficient and effective way to guide heart health decisions.
Future Directions: Questions That Still Need Answers
While the study is robust, the authors acknowledge that there is more work to be done to refine these risk assessments for diverse populations.
Demographics and Age
One limitation noted by the researchers is that the study cohort consisted of individuals between 45 and 79 years of age. Therefore, the findings may not be directly applicable to younger populations. Furthermore, Dr. Shah highlighted the need for more granular data on specific ethnic and racial groups. For instance, it remains to be seen how much predictive value calcium scores add to PREVENT equations for South Asian and Filipino adults, groups known to have distinct cardiovascular risk profiles that may not be fully captured by standard models.
Integrating New Technology
As medical technology evolves, the integration of new data points into the PREVENT calculator will be essential. The research team emphasizes that this study is not a critique of the technology itself, but rather a guide to its optimal application. Future research will likely focus on whether artificial intelligence or deeper imaging analytics can extract more value from the scans than simple calcium scoring does today.
Summary: A Call for Targeted Screening
The JAMA publication serves as a timely reminder that the most sophisticated diagnostic tools are not always the most useful ones. By focusing on the "borderline" patient, clinicians can ensure that the right tools are used for the right people, reducing healthcare waste and minimizing unnecessary radiation exposure.
For the average patient, the message is clear: trust the foundational metrics. Your cholesterol, blood pressure, and age remain the primary drivers of your heart health strategy. The coronary artery calcium scan, while powerful, is a specialized instrument meant for nuanced clinical decision-making, not a routine screening for all.
As we move toward a more personalized era of cardiology, the goal of the physician should be to minimize the "noise" of unnecessary testing and maximize the clarity of actionable, evidence-based care. The findings from Northwestern Medicine are a significant step toward that goal, proving that sometimes, the best way to improve patient outcomes is simply to use the tools we already have more intelligently.
Study Details:
- "Predictive Utility of Coronary Artery Calcium Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations."
- Publication: JAMA, August 26.
- Funding: The study was supported by the American Heart Association (grant 24CDA1266732) and the National Heart, Lung, and Blood Institute.
- Authors: Dr. Nilay Shah, Xiaoning Huang, Lucia Petito, Norrina Allen, Dr. Philip Greenland, and Dr. Sadiya Khan (Northwestern University Feinberg School of Medicine).
